Jizhong et al. showed that PD-L1 was expressed in most multiple myeloma (MM) plasma cells and inhibit T-cell functions, representing a possible immunoescape mechanism that could be targeted therapeutically through the inhibition of MyD88/TRAF6 and MEK/ERK/STAT1 [36]. The gene discussed is CD274; the disease is Miyoshi myopathy.